Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ILOPROST vs IMBRUVICA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ILOPROST vs IMBRUVICA: Safety Overview

Metric ILOPROST IMBRUVICA
Total FAERS Reports 4,961 242
Deaths Reported 2,277 74
Death Rate 45.9% 30.6%
Hospitalizations 2,324 125
Average Patient Age 57.9 yrs 72.1 yrs
% Female Patients 70.7% N/A
FDA Approval Date Aug 7, 2009 N/A
Manufacturer BTG International Inc N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A